Emageon Inc. Prices Initial Public Offering

Emageon Inc. Prices Initial Public Offering 


BIRMINGHAM, Ala., Feb. 9  /PRNewswire-FirstCall/ -- Emageon Inc. (NASDAQ:EMAG),
today announced the pricing of its initial public offering of 5,000,000 shares
of its common stock at a price of $13 a share.  All of the shares are being
sold by Emageon.  In addition, Emageon has granted to the underwriters a 30-day
over-allotment option to purchase up to an additional 750,000 shares. 
Emageon's common stock is expected to begin trading on The Nasdaq National
Market on February 9, 2005 under the symbol "EMAG."

Emageon's proceeds from the offering are expected to be approximately $58.45
million, or $67.52 million if the underwriters exercise their over- allotment
option in full, after deducting the underwriting discounts and commissions and
the estimated offering expenses. Emageon plans to use the net proceeds of this
offering to repay $4.0 million of its outstanding subordinated debt and for
general corporate purposes, including working capital, research and
development, sales and marketing, and capital expenditures.  Emageon may also
use a portion of the net proceeds for the acquisition of or investment in
businesses, products and technologies that are complementary to its offerings.

Wachovia Capital Markets, LLC and Piper Jaffray & Co. are the joint book-
running managers of the underwriting group.  Raymond James & Associates, Inc.
and Friedman, Billings, Ramsey & Co., Inc. are co-managers.

Copies of the final prospectus relating to the offering may be obtained by
contacting Wachovia Capital Markets, LLC, Syndicate Department, 7 St. Paul
Street, Baltimore, Maryland 21202 or Piper Jaffray & Co., 800 Nicollet Mall,
Suite 800, Minneapolis, Minnesota 55402.

This press release shall not constitute an offer to sell or the solicitation of
an offer to buy nor shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any such state or
jurisdiction. Any offer or sale will be made only by means of a written
prospectus forming part of the effective registration statement.

About Emageon

Emageon provides an enterprise-level information technology solution for the
clinical analysis and management of digital medical images within health care
provider organizations. 

DATASOURCE: Emageon Inc.



CONTACT:  Emageon Investor Relations, [phone],





Web site:  http://www.emageon.com/ 

Copyright